Skip to content

Insider · CIK 0001804186

Jean-Claude Kyrillos

cooofficer

Files at TNDM (TANDEM DIABETES CARE INC). First filing Mar 11, 2025, latest Mar 11, 2025.

In brief

Jean-Claude Kyrillos files SEC Form 4 as COO at TNDM (TANDEM DIABETES CARE INC). Since Mar 11, 2025, Jean-Claude Kyrillos has reported 1 open-market buy worth $191k and 0 open-market sells worth $0, the latest filed on Mar 11, 2025.

A track record needs three past buys with six months of prices behind them; Jean-Claude Kyrillos has 0, so none is measured yet.

The newest scored trade: bought $191k of TNDM on Mar 7, 2025, filed Mar 11, 2025, scored 40 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$191k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TNDM: TANDEM DIABETES CARE INC

TNDMOct 9, 2026 · close 16.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
TNDMbuy
TANDEM DIABETES CARE INC
$191k
10,538 shares
--

Transactions

Every row this insider has filed, 28 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+1,010$0.00$030,825Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-535$22.72$12k30,290Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-1,010$0.00$07,067Aug 18, 2026
Jul 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+3,636$0.00$031,741Jul 17, 2026
Jul 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-1,926$15.28$29k29,815Jul 17, 2026
Jul 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-3,636$0.00$014,545Jul 17, 2026
May 29, 2026TNDM
TANDEM DIABETES CARE INC
AGrant or award
Restricted Stock Unitderivative
+29,136$0.00$029,136Jun 2, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+4,038$0.00$029,810May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,139$12.82$27k27,671May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
AGrant or award
Common Stock
+434$10.90$4,73128,105May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-4,038$0.00$08,077May 19, 2026
Apr 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+3,636$0.00$027,698Apr 17, 2026
Apr 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-1,926$20.66$40k25,772Apr 17, 2026
Apr 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-3,636$0.00$018,181Apr 17, 2026
Jan 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+3,636$0.00$026,180Jan 20, 2026
Jan 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,118$21.07$45k24,062Jan 20, 2026
Jan 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-3,636$0.00$021,817Jan 20, 2026
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Common Stock
+160$15.59$2,49422,544Nov 19, 2025
Oct 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+3,636$0.00$023,685Oct 17, 2025
Oct 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-1,301$14.75$19k22,384Oct 17, 2025
Oct 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-3,636$0.00$025,453Oct 17, 2025
Jul 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+14,545$0.00$025,254Jul 17, 2025
Jul 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-5,205$15.20$79k20,049Jul 17, 2025
Jul 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-14,545$0.00$029,089Jul 17, 2025
May 30, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Performance Stock Unitderivative
+12,114$0.00$012,114Jun 5, 2025
May 30, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Restricted Stock Unitderivative
+12,115$0.00$012,115Jun 5, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Common Stock
+171$19.30$3,30010,709May 19, 2025
Mar 7, 2025TNDM
TANDEM DIABETES CARE INC
POpen-market purchase
Common Stock
+10,538$18.12$191k10,538Mar 11, 2025

Questions about Jean-Claude Kyrillos

Answered from the filings on this page, as of the latest one.

Is Jean-Claude Kyrillos buying or selling?

Not in the last 12 months. Jean-Claude Kyrillos's latest open-market trade on SEC Form 4 was bought $191k of TNDM on Mar 7, 2025.

How did Jean-Claude Kyrillos's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jean-Claude Kyrillos has 0.

Where does Jean-Claude Kyrillos file Form 4?

Jean-Claude Kyrillos has filed Form 4 at TNDM (TANDEM DIABETES CARE INC) as EVP & Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jean-Claude Kyrillos: insider trades and track record | InsiderTell